# Table 17 generation works with default values

    Code
      res
    Output
      FMQ (Narrow)                   A: Drug X   B: Placebo   C: Combination
        Preferred Term                (N=134)     (N=134)        (N=132)    
      ——————————————————————————————————————————————————————————————————————
      Abnormal Uterine Bleeding                                             
        dcd A.1.1.1.1                13 (9.7%)   10 (7.5%)      10 (7.6%)   
        dcd A.1.1.1.2                10 (7.5%)    9 (6.7%)      13 (9.8%)   
        dcd B.1.1.1.1                6 (4.5%)     7 (5.2%)       7 (5.3%)   
        dcd B.2.1.2.1                9 (6.7%)     8 (6.0%)       6 (4.5%)   
        dcd C.2.1.2.1                7 (5.2%)     8 (6.0%)      11 (8.3%)   
        dcd D.1.1.1.1                3 (2.2%)    13 (9.7%)       9 (6.8%)   
        dcd D.1.1.4.2                13 (9.7%)    8 (6.0%)       9 (6.8%)   
        dcd D.2.1.5.3                9 (6.7%)    11 (8.2%)      11 (8.3%)   
      Amenorrhea                                                            
        dcd A.1.1.1.1                7 (5.2%)     8 (6.0%)      16 (12.1%)  
        dcd A.1.1.1.2                12 (9.0%)   14 (10.4%)      6 (4.5%)   
        dcd B.1.1.1.1                9 (6.7%)    14 (10.4%)      9 (6.8%)   
        dcd B.2.1.2.1                13 (9.7%)   10 (7.5%)       8 (6.1%)   
        dcd C.2.1.2.1                6 (4.5%)     6 (4.5%)       9 (6.8%)   
        dcd D.1.1.1.1                11 (8.2%)    6 (4.5%)       8 (6.1%)   
        dcd D.1.1.4.2                8 (6.0%)     3 (2.2%)       4 (3.0%)   
        dcd D.2.1.5.3                7 (5.2%)    13 (9.7%)       8 (6.1%)   
      Bacterial Vaginosis                                                   
        dcd A.1.1.1.1                8 (6.0%)     9 (6.7%)       5 (3.8%)   
        dcd A.1.1.1.2                6 (4.5%)     9 (6.7%)       8 (6.1%)   
        dcd B.1.1.1.1                10 (7.5%)    9 (6.7%)       6 (4.5%)   
        dcd B.2.1.2.1                9 (6.7%)    10 (7.5%)       5 (3.8%)   
        dcd C.2.1.2.1                7 (5.2%)    12 (9.0%)       5 (3.8%)   
        dcd D.1.1.1.1                8 (6.0%)    11 (8.2%)       7 (5.3%)   
        dcd D.1.1.4.2                8 (6.0%)     7 (5.2%)      12 (9.1%)   
        dcd D.2.1.5.3                7 (5.2%)    11 (8.2%)       9 (6.8%)   
      Decreased Menstrual Bleeding                                          
        dcd A.1.1.1.1                12 (9.0%)   13 (9.7%)       9 (6.8%)   
        dcd A.1.1.1.2                10 (7.5%)   11 (8.2%)       7 (5.3%)   
        dcd B.1.1.1.1                6 (4.5%)     6 (4.5%)       8 (6.1%)   
        dcd B.2.1.2.1                5 (3.7%)    12 (9.0%)       6 (4.5%)   
        dcd C.2.1.2.1                8 (6.0%)    13 (9.7%)       8 (6.1%)   
        dcd D.1.1.1.1                8 (6.0%)     6 (4.5%)      11 (8.3%)   
        dcd D.1.1.4.2                9 (6.7%)     8 (6.0%)       8 (6.1%)   
        dcd D.2.1.5.3                11 (8.2%)   12 (9.0%)      12 (9.1%)   

# Table 17 generation works with custom values

    Code
      res
    Output
      Table 17: Patients With Adverse Events by Female-Specific FDA Medical Query (Narrow) and Preferred Term, Female Safety Population, Pooled Analyses
      
      ——————————————————————————————————————————————————————————————————————
      FMQ (Narrow)                   A: Drug X   B: Placebo   C: Combination
        Preferred Term                (N=134)     (N=134)        (N=132)    
      ——————————————————————————————————————————————————————————————————————
      Abnormal Uterine Bleeding                                             
        dcd A.1.1.1.1                13 (9.7%)   10 (7.5%)      10 (7.6%)   
        dcd A.1.1.1.2                10 (7.5%)    9 (6.7%)      13 (9.8%)   
        dcd B.1.1.1.1                6 (4.5%)     7 (5.2%)       7 (5.3%)   
        dcd B.2.1.2.1                9 (6.7%)     8 (6.0%)       6 (4.5%)   
        dcd C.2.1.2.1                7 (5.2%)     8 (6.0%)      11 (8.3%)   
        dcd D.1.1.1.1                3 (2.2%)    13 (9.7%)       9 (6.8%)   
        dcd D.1.1.4.2                13 (9.7%)    8 (6.0%)       9 (6.8%)   
        dcd D.2.1.5.3                9 (6.7%)    11 (8.2%)      11 (8.3%)   
      Amenorrhea                                                            
        dcd A.1.1.1.1                7 (5.2%)     8 (6.0%)      16 (12.1%)  
        dcd A.1.1.1.2                12 (9.0%)   14 (10.4%)      6 (4.5%)   
        dcd B.1.1.1.1                9 (6.7%)    14 (10.4%)      9 (6.8%)   
        dcd B.2.1.2.1                13 (9.7%)   10 (7.5%)       8 (6.1%)   
        dcd C.2.1.2.1                6 (4.5%)     6 (4.5%)       9 (6.8%)   
        dcd D.1.1.1.1                11 (8.2%)    6 (4.5%)       8 (6.1%)   
        dcd D.1.1.4.2                8 (6.0%)     3 (2.2%)       4 (3.0%)   
        dcd D.2.1.5.3                7 (5.2%)    13 (9.7%)       8 (6.1%)   
      Bacterial Vaginosis                                                   
        dcd A.1.1.1.1                8 (6.0%)     9 (6.7%)       5 (3.8%)   
        dcd A.1.1.1.2                6 (4.5%)     9 (6.7%)       8 (6.1%)   
        dcd B.1.1.1.1                10 (7.5%)    9 (6.7%)       6 (4.5%)   
        dcd B.2.1.2.1                9 (6.7%)    10 (7.5%)       5 (3.8%)   
        dcd C.2.1.2.1                7 (5.2%)    12 (9.0%)       5 (3.8%)   
        dcd D.1.1.1.1                8 (6.0%)    11 (8.2%)       7 (5.3%)   
        dcd D.1.1.4.2                8 (6.0%)     7 (5.2%)      12 (9.1%)   
        dcd D.2.1.5.3                7 (5.2%)    11 (8.2%)       9 (6.8%)   
      Decreased Menstrual Bleeding                                          
        dcd A.1.1.1.1                12 (9.0%)   13 (9.7%)       9 (6.8%)   
        dcd A.1.1.1.2                10 (7.5%)   11 (8.2%)       7 (5.3%)   
        dcd B.1.1.1.1                6 (4.5%)     6 (4.5%)       8 (6.1%)   
        dcd B.2.1.2.1                5 (3.7%)    12 (9.0%)       6 (4.5%)   
        dcd C.2.1.2.1                8 (6.0%)    13 (9.7%)       8 (6.1%)   
        dcd D.1.1.1.1                8 (6.0%)     6 (4.5%)      11 (8.3%)   
        dcd D.1.1.4.2                9 (6.7%)     8 (6.0%)       8 (6.1%)   
        dcd D.2.1.5.3                11 (8.2%)   12 (9.0%)      12 (9.1%)   
      ——————————————————————————————————————————————————————————————————————
      
      Source: [include Applicant source, datasets and/or software tools used].
       (1) Treatment-emergent adverse event defined as [definition]. MedDRA version X.
       (2) Duration = [e.g., X week double-blind treatment period or median and a range indicating pooled trial durations].
       (3) Difference is shown between [treatment arms] (e.g., difference is shown between Drug Name dosage X vs. placebo).
      
      Abbreviations: CI, confidence interval;
      FMQ, FDA Medical Query;
      MedDRA, Medical Dictionary for Regulatory Activities;
      N, number of patients in treatment arm;
      n, number of patients with at least one event;
      PT, preferred term

# Table 17 generation works with NA values/pruned rows

    Code
      res
    Output
      FMQ (Narrow)                   A: Drug X   B: Placebo   C: Combination
        Preferred Term                (N=134)     (N=134)        (N=132)    
      ——————————————————————————————————————————————————————————————————————
      Abnormal Uterine Bleeding                                             
        dcd A.1.1.1.1                13 (9.7%)   10 (7.5%)      10 (7.6%)   
        dcd A.1.1.1.2                10 (7.5%)    9 (6.7%)      13 (9.8%)   
        dcd B.1.1.1.1                6 (4.5%)     7 (5.2%)       7 (5.3%)   
        dcd B.2.1.2.1                9 (6.7%)     8 (6.0%)       6 (4.5%)   
        dcd C.2.1.2.1                7 (5.2%)     8 (6.0%)      11 (8.3%)   
        dcd D.1.1.1.1                3 (2.2%)    13 (9.7%)       9 (6.8%)   
        dcd D.1.1.4.2                13 (9.7%)    8 (6.0%)       9 (6.8%)   
        dcd D.2.1.5.3                9 (6.7%)    11 (8.2%)      11 (8.3%)   
      Amenorrhea                                                            
        dcd A.1.1.1.1                7 (5.2%)     8 (6.0%)      16 (12.1%)  
        dcd A.1.1.1.2                12 (9.0%)   14 (10.4%)      6 (4.5%)   
        dcd B.1.1.1.1                9 (6.7%)    14 (10.4%)      9 (6.8%)   
        dcd B.2.1.2.1                13 (9.7%)   10 (7.5%)       8 (6.1%)   
        dcd C.2.1.2.1                6 (4.5%)     6 (4.5%)       9 (6.8%)   
        dcd D.1.1.1.1                11 (8.2%)    6 (4.5%)       8 (6.1%)   
        dcd D.1.1.4.2                8 (6.0%)     3 (2.2%)       4 (3.0%)   
        dcd D.2.1.5.3                7 (5.2%)    13 (9.7%)       8 (6.1%)   
      Bacterial Vaginosis                                                   
        dcd A.1.1.1.1                8 (6.0%)     9 (6.7%)       5 (3.8%)   
        dcd A.1.1.1.2                6 (4.5%)     9 (6.7%)       8 (6.1%)   
        dcd B.1.1.1.1                10 (7.5%)    9 (6.7%)       6 (4.5%)   
        dcd B.2.1.2.1                9 (6.7%)    10 (7.5%)       5 (3.8%)   
        dcd C.2.1.2.1                7 (5.2%)    12 (9.0%)       5 (3.8%)   
        dcd D.1.1.1.1                8 (6.0%)    11 (8.2%)       7 (5.3%)   
        dcd D.1.1.4.2                8 (6.0%)     7 (5.2%)      12 (9.1%)   
        dcd D.2.1.5.3                7 (5.2%)    11 (8.2%)       9 (6.8%)   
      Decreased Menstrual Bleeding                                          
        dcd A.1.1.1.1                12 (9.0%)   13 (9.7%)       9 (6.8%)   
        dcd A.1.1.1.2                10 (7.5%)   11 (8.2%)       7 (5.3%)   
        dcd B.1.1.1.1                6 (4.5%)     6 (4.5%)       8 (6.1%)   
        dcd B.2.1.2.1                5 (3.7%)    12 (9.0%)       6 (4.5%)   
        dcd C.2.1.2.1                8 (6.0%)    13 (9.7%)       8 (6.1%)   
        dcd D.1.1.1.1                8 (6.0%)     6 (4.5%)      11 (8.3%)   
        dcd D.1.1.4.2                9 (6.7%)     8 (6.0%)       8 (6.1%)   
        dcd D.2.1.5.3                11 (8.2%)   12 (9.0%)      12 (9.1%)   

# Table 17 generation works with risk difference column

    Code
      res
    Output
      FMQ (Narrow)                   A: Drug X   B: Placebo   C: Combination   Risk Difference (%) (95% CI)
        Preferred Term                (N=134)     (N=134)        (N=132)                 (N=266)           
      —————————————————————————————————————————————————————————————————————————————————————————————————————
      Abnormal Uterine Bleeding                                                                            
        dcd A.1.1.1.1                13 (9.7%)   10 (7.5%)      10 (7.6%)            2.1 (-4.6 - 8.9)      
        dcd A.1.1.1.2                10 (7.5%)    9 (6.7%)      13 (9.8%)           -2.4 (-9.1 - 4.4)      
        dcd B.1.1.1.1                6 (4.5%)     7 (5.2%)       7 (5.3%)           -0.8 (-6.0 - 4.4)      
        dcd B.2.1.2.1                9 (6.7%)     8 (6.0%)       6 (4.5%)            2.2 (-3.4 - 7.7)      
        dcd C.2.1.2.1                7 (5.2%)     8 (6.0%)      11 (8.3%)           -3.1 (-9.1 - 2.9)      
        dcd D.1.1.1.1                3 (2.2%)    13 (9.7%)       9 (6.8%)           -4.6 (-9.6 - 0.4)      
        dcd D.1.1.4.2                13 (9.7%)    8 (6.0%)       9 (6.8%)            2.9 (-3.7 - 9.5)      
        dcd D.2.1.5.3                9 (6.7%)    11 (8.2%)      11 (8.3%)           -1.6 (-8.0 - 4.7)      
      Amenorrhea                                                                                           
        dcd A.1.1.1.1                7 (5.2%)     8 (6.0%)      16 (12.1%)         -6.9 (-13.6 - -0.2)     
        dcd A.1.1.1.2                12 (9.0%)   14 (10.4%)      6 (4.5%)           4.4 (-1.6 - 10.4)      
        dcd B.1.1.1.1                9 (6.7%)    14 (10.4%)      9 (6.8%)           -0.1 (-6.1 - 5.9)      
        dcd B.2.1.2.1                13 (9.7%)   10 (7.5%)       8 (6.1%)           3.6 (-2.8 - 10.1)      
        dcd C.2.1.2.1                6 (4.5%)     6 (4.5%)       9 (6.8%)           -2.3 (-7.9 - 3.2)      
        dcd D.1.1.1.1                11 (8.2%)    6 (4.5%)       8 (6.1%)            2.1 (-4.0 - 8.3)      
        dcd D.1.1.4.2                8 (6.0%)     3 (2.2%)       4 (3.0%)            2.9 (-2.0 - 7.9)      
        dcd D.2.1.5.3                7 (5.2%)    13 (9.7%)       8 (6.1%)           -0.8 (-6.4 - 4.7)      
      Bacterial Vaginosis                                                                                  
        dcd A.1.1.1.1                8 (6.0%)     9 (6.7%)       5 (3.8%)            2.2 (-3.0 - 7.3)      
        dcd A.1.1.1.2                6 (4.5%)     9 (6.7%)       8 (6.1%)           -1.6 (-7.0 - 3.8)      
        dcd B.1.1.1.1                10 (7.5%)    9 (6.7%)       6 (4.5%)            2.9 (-2.8 - 8.6)      
        dcd B.2.1.2.1                9 (6.7%)    10 (7.5%)       5 (3.8%)            2.9 (-2.4 - 8.3)      
        dcd C.2.1.2.1                7 (5.2%)    12 (9.0%)       5 (3.8%)            1.4 (-3.5 - 6.4)      
        dcd D.1.1.1.1                8 (6.0%)    11 (8.2%)       7 (5.3%)            0.7 (-4.9 - 6.2)      
        dcd D.1.1.4.2                8 (6.0%)     7 (5.2%)      12 (9.1%)           -3.1 (-9.5 - 3.2)      
        dcd D.2.1.5.3                7 (5.2%)    11 (8.2%)       9 (6.8%)           -1.6 (-7.3 - 4.1)      
      Decreased Menstrual Bleeding                                                                         
        dcd A.1.1.1.1                12 (9.0%)   13 (9.7%)       9 (6.8%)            2.1 (-4.3 - 8.6)      
        dcd A.1.1.1.2                10 (7.5%)   11 (8.2%)       7 (5.3%)            2.2 (-3.7 - 8.0)      
        dcd B.1.1.1.1                6 (4.5%)     6 (4.5%)       8 (6.1%)           -1.6 (-7.0 - 3.8)      
        dcd B.2.1.2.1                5 (3.7%)    12 (9.0%)       6 (4.5%)           -0.8 (-5.6 - 4.0)      
        dcd C.2.1.2.1                8 (6.0%)    13 (9.7%)       8 (6.1%)           -0.1 (-5.8 - 5.6)      
        dcd D.1.1.1.1                8 (6.0%)     6 (4.5%)      11 (8.3%)           -2.4 (-8.6 - 3.8)      
        dcd D.1.1.4.2                9 (6.7%)     8 (6.0%)       8 (6.1%)            0.7 (-5.2 - 6.5)      
        dcd D.2.1.5.3                11 (8.2%)   12 (9.0%)      12 (9.1%)           -0.9 (-7.6 - 5.9)      

